Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Oragenics Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 13 | 15 | +2 |
| Shares | 61.4K | 62.1K | +698 (+1.1%) |
| Value | $182.1K | $349.5K | +$167.4K (+91.9%) |
New holders (2)
Institutions that held Oragenics Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 4 | $23 | 0.00% |
| Northwestern Mutual Wealth Management Co | 1 | $6 | 0.00% |
Sold out (0)
Institutions that held Oragenics Inc at the end of Q3 2023 and filed for Q4 2023 without it.
None.